<PAGE>
UNITED STATED
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
AND RULE 13A-17 OR 15D-17 THEREUNDER
RoTech Medical Corporation
-----------------------------------------------------------
(Exact name of issuer as specified in charter)
4506 L. B. McLeod Road, Suite F., Orlando, FL 32811
-----------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (407) 841-2115
---------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security Common Stock, par value $.0002
----------------------------------------------------------
2. Number of shares outstanding before the change 9,591,623
------------------------------
3. Number of shares outstanding after the change 11,367,000
------------------------------
4. Effective date of change May 10, 1995
--------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.) Public
------------
offering of Common Stock
---------------------------------------------------------------------------
Give brief description of transaction The Company, through Smith Barney
--------------------------------------
Inc. and Needham & Company, Inc., sold to the public, in a firm commitment
---------------------------------------------------------------------------
underwriting, 1,700,000 shares of previously authorized but unissued
---------------------------------------------------------------------------
shares of Common Stock.
---------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
------------------------------------------------------
2. Name after change
---------------------------------------------------------
3. Effective date of charter amendment changing name
-------------------------
4. Date of shareholder approval of change, if required
-----------------------
RoTech Medical Corporation
By: /s/ Rebecca R. Irish
------------------------------------
Date May 15, 1995 Rebecca R. Irish, Treasurer and Chief
----------------------- Financial Officer
